Alivus Life Sciences Limited (NSE:ALIVUS)
1,048.00
-7.50 (-0.71%)
Jun 1, 2026, 3:30 PM IST
Alivus Life Sciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 21.32 | 710.62 | 3,014 | 2,838 | 5,122 |
Short-Term Investments | 7,804 | 4,776 | - | - | 1.11 |
Cash & Short-Term Investments | 7,825 | 5,487 | 3,014 | 2,838 | 5,123 |
Cash Growth | 42.62% | 82.03% | 6.20% | -44.59% | 332.66% |
Accounts Receivable | 10,730 | 9,697 | 7,654 | 8,068 | 6,735 |
Other Receivables | 322.92 | 398.65 | 903.68 | 709.4 | 57.94 |
Receivables | 11,053 | 10,096 | 8,558 | 8,777 | 6,793 |
Inventory | 6,919 | 6,739 | 6,666 | 6,042 | 5,162 |
Prepaid Expenses | - | 22.56 | 8.06 | 1.38 | 1.63 |
Other Current Assets | 696.61 | 1,007 | 913.88 | 845.01 | 566.28 |
Total Current Assets | 26,494 | 23,352 | 19,160 | 18,503 | 17,646 |
Property, Plant & Equipment | 12,914 | 10,369 | 8,962 | 8,242 | 6,763 |
Long-Term Investments | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 |
Other Intangible Assets | 299.26 | 199.37 | 148.53 | 180.01 | 103.8 |
Other Long-Term Assets | 121.57 | 193.59 | 232.86 | 94.86 | 196.3 |
Total Assets | 39,829 | 34,115 | 28,504 | 27,021 | 24,710 |
Accounts Payable | 3,724 | 3,905 | 3,687 | 4,272 | 3,077 |
Accrued Expenses | 299.11 | 479.38 | 385.91 | 361.1 | 447.76 |
Current Portion of Leases | 79.77 | 56.48 | 23.87 | 22.65 | 16.8 |
Current Income Taxes Payable | 64.58 | - | - | 70.78 | 120.03 |
Current Unearned Revenue | - | 29.67 | 52.58 | 19.43 | - |
Other Current Liabilities | 913.22 | 231.42 | 238.76 | 219.21 | 178.19 |
Total Current Liabilities | 5,080 | 4,702 | 4,388 | 4,965 | 3,840 |
Long-Term Leases | 487.94 | 509.58 | 147.61 | 170.92 | 12.04 |
Pension & Post-Retirement Benefits | 361.48 | 185.35 | 157.71 | 78.7 | - |
Long-Term Deferred Tax Liabilities | 577.88 | 544.29 | 487.85 | 424.34 | 314.95 |
Total Liabilities | 6,508 | 5,941 | 5,181 | 5,639 | 4,167 |
Common Stock | 245.47 | 245.07 | 245.05 | 245.05 | 245.05 |
Additional Paid-In Capital | - | 10,057 | 10,050 | 10,050 | 10,050 |
Retained Earnings | - | 17,772 | 12,918 | 11,021 | 10,214 |
Comprehensive Income & Other | 33,076 | 99.69 | 110.58 | 66.83 | 34.98 |
Shareholders' Equity | 33,321 | 28,174 | 23,323 | 21,382 | 20,543 |
Total Liabilities & Equity | 39,829 | 34,115 | 28,504 | 27,021 | 24,710 |
Total Debt | 567.71 | 566.06 | 171.48 | 193.57 | 28.84 |
Net Cash (Debt) | 7,257 | 4,921 | 2,843 | 2,645 | 5,094 |
Net Cash Growth | 47.49% | 73.10% | 7.49% | -48.08% | - |
Net Cash Per Share | 59.01 | 40.04 | 23.17 | 21.58 | 43.34 |
Filing Date Shares Outstanding | 122.95 | 122.54 | 122.53 | 122.53 | 122.53 |
Total Common Shares Outstanding | 122.95 | 122.54 | 122.53 | 122.53 | 122.53 |
Working Capital | 21,413 | 18,650 | 14,772 | 13,538 | 13,806 |
Book Value Per Share | 271.02 | 229.92 | 190.35 | 174.51 | 167.66 |
Tangible Book Value | 33,022 | 27,974 | 23,175 | 21,202 | 20,439 |
Tangible Book Value Per Share | 268.58 | 228.29 | 189.14 | 173.04 | 166.81 |
Buildings | - | 3,678 | 3,164 | 3,017 | 2,235 |
Machinery | - | 7,225 | 6,273 | 5,743 | 4,426 |
Construction In Progress | - | 942.52 | 1,012 | 493.54 | 916.88 |